Home / Business Scene / New Issue of Lider: The Term of State Managers is Only Two Years

New Issue of Lider: The Term of State Managers is Only Two Years

Lider’s research has shown that the term of Milanović’s appointees at the helm of state companies is only two years. A new series of changes is forthcoming, and Most and HDZ are still negotiating whether to select state directors through competitions or appoint them politically.

However, the CEOs of state companies cannot really complain. Whether they have been at the helm for three, four, or just two years, they do not leave empty-handed – generous severance packages, salaries averaging 17,000 kuna for the next six months to a year, or a new job, writes Jasmina Trstenjak in the weekly topic in the new issue of Lider.

Although small and medium-sized enterprises are less indebted than large ones, they do not have adequate collateral. Financing for small and medium-sized enterprises could be stimulated by new guarantee schemes. However, the state should first encourage all domestic and foreign financiers, writes Gordana Gelenčer in an article on over-indebtedness, claiming that banks are swimming in money, so the state can help companies with loan guarantees.

In the ‘Character and Work’ section, we present the new director of the Tax Administration, Zdravko Zrinušić, who could introduce a new philosophy in the approach of this unpopular body towards entrepreneurs. Efficient and transparent tax collection and the reorganization of the Tax Administration system are key tasks set by the Minister of Finance for its new head. Therefore, entrepreneurs have high hopes for the Marić – Zrinušić tandem, who has experience from the private sector.

We also bring an interview with Helena Miloloža, one of the youngest PhD holders in Croatia, who has already gained rich experience in both the private and public sectors despite her youth.

In the world section, we write about the relations between Great Britain and the EU, as well as about Martin Shkreli, the most hated man in America, who in September last year bought the license for an AIDS drug and literally overnight raised its price by 5,500%.